NewLink Genetics to Participate in Upcoming Investor Conferences
- Oppenheimer 28th Annual Healthcare Conference,
March 20, 2018in New York City
- 8th Annual
Cancer Immunotherapy Conference, hosted by William Blair & Companyand MaidStone Life Sciences, April 5, 2018in New York City
At the Oppenheimer 28th Annual Healthcare Conference, NewLink Genetics’ participation will consist of one-on-one meetings with investors.
At the 8th Annual
About NewLink Genetics Corporation
NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer.
Director of Investor Relations
617-374-8800, ext. 105
Source: NewLink Genetics Corporation